A Physiological Barrier Distal to the Anatomic Blood-Brain Barrier in a Model of Transvascular Delivery

References

1. ↵
   Kroll RA, Neuwelt EA. Outwitting the blood-brain barrier for therapeutic purposes: osmotic opening and other means. Neurosurgery 1998;42:1083-1100

   CrossRefPubMedWeb of Science
2. Pardridge WM. Drug delivery to the brain. J Cereb Blood Flow Metab 1997;17:713-731

   CrossRefPubMedWeb of Science
3. ↵
   Brightman MW, Hori M, Rapoport SI, Reese TS, Westergaard E. Osmotic opening of tight junctions in cerebral endothelium. J Comp Neurol 1973;152:317-326

   CrossRefPubMedWeb of Science
4. Rapoport SI, Robinson PJ. Tight-junctional modification as the basis of osmotic opening of the blood-brain barrier. Ann N Y Acad Sci 1986;481:250-267

   CrossRefPubMed
5. Dahlborg SA, Henner WD, Crossen JR, et al. Non-AIDS primary CNS lymphoma: the first example of durable response in a primary brain tumor using enhance chemotherapy delivery without cognitive loss and without radiotherapy. Cancer J Sci Am 1996;2:166-174

   PubMed
6. ↵
   Doran SE, Dan Ren X, Betz AL, et al. Gene expression from recombinant viral vectors in the CNS following blood-brain barrier disruption. Neurosurgery 1995;36:965-970

   PubMedWeb of Science
7. ↵
   Muldoon LL, Nilaver G, Kroll RA, et al. Comparison of intracerebral inoculation and osmotic blood-brain barrier disruption for delivery of adenovirus, herpesvirus and iron oxide particles to normal rat brain. Am J Pathol 1995;147:1840-1851

   PubMedWeb of Science
8. Nilaver G, Muldoon LL, Kroll RA, et al. Delivery of herpesvirus and adenovirus to nude rat intracerebral tumors following osmotic blood-brain barrier disruption. Proc Natl Acad Sci U S A 1995;92:9829-9833

   Abstract/FREE Full Text
9. Neuwelt EA, Pagel MA, Dix RD. Delivery of UV-inactivated [35S]-herpesvirus across the BBB after osmotic modification. J Neurosurg 1991;74:475-479

   CrossRefPubMedWeb of Science
10. ↵
    Weissleder R, Elizondo G, Wittenberg J, Rabito CA, Bengele HH, Josephson L. Ultrasmall superparamagnetic iron oxide: characterization of a new class of contrast agents for MR imaging. Radiology 1990;175:489-493

    PubMedWeb of Science
11. ↵
    Shen T, Weissleder R, Papisov M, Bogdanov A Jr, Brady TJ. Monocrystalline iron oxide nanocompounds (MION): physicochemical properties. Magn Reson Med 1993;29:599-604

    PubMedWeb of Science
12. ↵
    Neuwelt EA, Weissleder R, Nilaver G, et al. Delivery of virus-sized iron oxide particles to rodent CNS neurons. Neurosurgery 1994;34:777-784

    PubMedWeb of Science
13. ↵
    Jung CW. Surface properties of superparamagnetic iron oxide MR contrast agents: ferumoxides, ferumoxtran, ferumoxsil. Magn Reson Imaging 1995;13:675-691

    CrossRefPubMedWeb of Science
14. ↵
    Jung CW, Jacobs P. Physical and chemical properties of superparamagnetic iron oxide MR contrast agents: ferumoxides, ferumoxtran, ferumoxsil. Magn Reson Imaging 1995;13:661-674

    CrossRefPubMedWeb of Science
15. ↵
    Triguero D, Buciak J, Pardridge WM. Capillary depletion method for quantification of blood-brain barrier transport of circulating peptides and plasma proteins. J Neurochemistry 1990;54:1882-1888

    CrossRefPubMedWeb of Science
16. ↵
    Walrus LR, Pardridge WM, Starzyk RM, Friden PM. Enhanced uptake of rsCD4 across the rodent and primate blood-brain barrier after conjugation to anti-transferrin receptor antibodies. J Pharmacol Exp Ther 1996;277:1067-1075

    Abstract/FREE Full Text
17. ↵
    Matsukado K, Inamura T, Nakano S, Fukui M, Bartus RT, Black KL. Enhanced tumor uptake of carboplatin and survival in glioma-bearing rats by intracarotid infusion of bradykinin analog, RMP-7. Neurosurgery 1996;39:125-133

    CrossRefPubMedWeb of Science
18. ↵
    Vorbrodt AW, Dobrogowska DH, Tarnawski M, Lossinsky AS. A quantitative immunocytochemical study of the osmotic opening of the blood-brain barrier to endogenous albumin. J Neurocytol 1994;23:792-800

    CrossRefPubMedWeb of Science
19. ↵
    Aihara N, Tanno H, Hall JJ, Pitts LH, Noble LJ. Immunocytochemical localization of immunoglobulins in the rat brain: relationship to the blood-brain barrier. J Comp Neurol 1994;342:481-496

    CrossRefPubMedWeb of Science
20. ↵
    Mundel P, Kriz W. Structure and function of podocytes: an update. Anat Embryol 1995;192:385-397

    PubMed
21. ↵
    Gehrmann J, Matsumoto Y, Kreutzberg GW. Microglia: intrinsic immuneffector cell of the brain. Brain Res Rev 1995;20:269-287

    CrossRefPubMedWeb of Science